Showing results (1501-1510 of 1,812) with videos related to

Sort By:
Pageof 182
Archives of Neurology|March 15, 2006
Association of apolipoprotein E genotype and Alzheimer disease in African AmericansJill R Murrell, Brandon Price, Kathleen A Lane, et al.
Molecular Cancer Therapeutics|May 17, 2008
Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumorsGunnar Johansson, Yonatan Y Mahller, Margaret H Collins, et al.
Mycological Research|June 14, 2006
Transformation of the ryegrass endophyte Neotyphodium lolii can alter its in planta mycelial morphologyNingxin Zhang, Vicki Scott, Taha H Al-Samarrai, et al.
International Psychogeriatrics|August 1, 2013
Homocysteine levels and dementia risk in Yoruba and African AmericansHugh C Hendrie, Olusegun Baiyewu, Kathleen A Lane, et al.
Expert Opinion on Drug Discovery|June 1, 2012
Research and innovation in the development of everolimus for oncologyDavid Lebwohl, George Thomas, Heidi A Lane, et al.
Neurology|November 7, 2007
Association of statin use with cognitive decline in elderly African AmericansS J Szwast, H C Hendrie, K A Lane, et al.
ESC Heart Failure|June 14, 2024
Development of a quality of life measure for left ventricular assist device recipients using a mixed methods approachAnita L Slade, Christel McMullan, M Sayeed Haque, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 21, 2001
Indium-cadmium-oxide films having exceptional electrical conductivity and optical transparency: clues for optimizing transparent conductorsA Wang, J R Babcock, N L Edleman, et al.
The Journal of Biological Chemistry|September 13, 2012
Structure and location of the regulatory β subunits in the (αβγδ)4 phosphorylase kinase complexOwen W Nadeau, Laura A Lane, Dong Xu, et al.
Neurology|July 14, 2010
Use of anticholinergics and the risk of cognitive impairment in an African American populationN L Campbell, M A Boustani, K A Lane, et al.
Pageof 182